Hepatitis B virus genotypes in acute and fulminant hepatitis patients from north India using two different molecular genotyping approaches

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Saket ChattopadhyayPremashis Kar

Abstract

Data from India on hepatitis B virus (HBV) genotype related differences in clinical progression and outcome of acute and fulminant hepatitis B are limited. Sera from patients with acute hepatitis B (AHB) (n=80), fulminant hepatitis B (FHB) (n=40) and asymptomatic HBsAg carriers (ASC) (n=40) were tested for HBV genotype using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and type-specific primers-based PCR (TSP-PCR). The genotype distribution for 160 patients with HBV related hepatitis/carriers were as follows: A, 3/80 (3.7%) in AHB, 2/40 (5%) in FHB and 7/40 (17.5%) in ASC; D, 77/80 (96.2%) in AHB, 38/40 (95%) in FHB and 33/40 (82.5%) in ASC. C, 0; B, 0; E, 0; F, 0 (p<0.01, genotype D versus A). Compared with genotype D, genotype A patients had no significant clinical or biochemical differences (p>0.05). HBV genotypes A and D were found to be prevalent in patients with HBV related acute and fulminant hepatitis from New Delhi, India. Genotype D was the dominant genotype prevalent in all patient categories while genotype A was solely responsible for AHB leading to chronic hepatitis B in 3.7% of the cases from this region.

References

Oct 1, 1994·Journal of Medical Virology·C NielS A Gomes
Dec 22, 1999·Journal of Viral Hepatitis·C MayeratP C Frei
Aug 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E OritoM Mizokami
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Varsha ThakurShiv Kumar Sarin
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chi-Jen Chu, Anna S F Lok
Jul 9, 2002·Journal of Gastroenterology and Hepatology·Jia-Horng Kao
Oct 16, 2004·Clinics in Liver Disease·Chun-Tao Wai, Robert J Fontana
Feb 22, 2005·Journal of Viral Hepatitis·S Schaefer
Feb 22, 2005·Journal of Viral Hepatitis·C-T WaiUNKNOWN US Acute Liver Failure Study Group
Mar 22, 2005·Journal of Medical Virology·Yoshiyuki SuzukiHiromitsu Kumada

❮ Previous
Next ❯

Citations

Nov 22, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Hans L TillmannGeorge N Dalekos
Feb 17, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Fuat KurbanovMasashi Mizokami
Jan 27, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hidenori ToyodaHsin-Fu Liu
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kaushal MadanSubrat K Acharya
Dec 14, 2018·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Mushtaq Ahmad KhanZaffar Ali Wani
Feb 22, 2008·Journal of Clinical Microbiology·Suzan D PasHubert G M Niesters

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.